Find clinical trials for Breast Cancer in Toronto, ON
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Toronto, ON, CAN:
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Toronto, Canada and 71 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Toronto, Ontario, Canada and 319 other locations
to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...
Phase 1, Phase 2
Toronto, Ontario, Canada and 57 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Toronto, Ontario, Canada and 144 other locations
medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...
Phase 1, Phase 2
Toronto, Ontario, Canada and 37 other locations
medicines for the potential treatment of advanced or metastatic breast cancer.This study is seeking participants who have breast...
Phase 1, Phase 2
Toronto, Ontario, Canada and 28 other locations
The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...
Phase 3
Toronto, Ontario, Canada and 257 other locations
or letrozole) in patients with advanced hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-negative) breast...
Phase 1
Toronto, Ontario, Canada and 5 other locations
with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...
Phase 3
Toronto, Ontario, Canada and 166 other locations
The purpose of this study is to find out the effect that CFI-400945 and durvalumab have on breast cancer....
Phase 2
Toronto, Ontario, Canada and 4 other locations
Clinical trials
Research sites
Resources
Legal